Process for the stereoselective reduction of steroid enelactams

Details Process for the stereoselective reduction of steroid enelactams Process for the stereoselective reduction of steroid enelactams

1995-07-28

1997-12-09

Daus, Donald G.

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

546 78, C07D22118

Patent

active

056962665

ABSTRACT:
The novel process of this invention involves the reduction of certain .DELTA.-5 steroidal alkenes to selectively produce either the 5.alpha. or 5.beta. reduction products. Particularly, this invention involves reduction of .DELTA.-5 steroidal alkenes using a rhodium based catalyst in the presence of hydrogen to selectively yield 5.alpha. steroids or alternatively reduction of .DELTA.-5 steroidal alkenes in an ionizing medium with a trialkylsilane to selectively yield 5.beta. steroids.

REFERENCES:
patent: 4220775 (1980-09-01), Rasmusson et al.
patent: 4377584 (1983-03-01), Rasmusson et al.
patent: 4760071 (1988-07-01), Rasmusson et al.
patent: 4845104 (1989-07-01), Carlin et al.
patent: 5049562 (1991-09-01), Rasmusson et al.
patent: 5061801 (1991-10-01), Williams et al.
patent: 5061802 (1991-10-01), Steinberg et al.
patent: 5061803 (1991-10-01), Williams
patent: 5075450 (1991-12-01), Rasmusson et al.
patent: 5091380 (1992-02-01), Rasmusson et al.
patent: 5091534 (1992-02-01), King et al.
patent: 5098908 (1992-03-01), Steinberg et al.
patent: 5120742 (1992-06-01), Rasmusson et al.
patent: 5138063 (1992-08-01), Rasmusson et al.
patent: 5151429 (1992-09-01), Rasmusson et al.
patent: 5151430 (1992-09-01), Steinberg et al.
patent: 5162332 (1992-11-01), Taylor et al.
patent: 5196411 (1993-03-01), Rasmusson et al.
patent: 5215894 (1993-06-01), Arison et al.
patent: 5237061 (1993-08-01), Bhattacharya et al.
patent: 5237064 (1993-08-01), Bakshi et al.
patent: 5237067 (1993-08-01), Schumaker
patent: 5278159 (1994-01-01), Bakashi et al.
patent: 5304562 (1994-04-01), Biollaz
patent: 5324734 (1994-06-01), Gilbert et al.
patent: 5470976 (1995-11-01), Humphrey et al.
patent: 5525608 (1996-06-01), Adams et al.
patent: 5536727 (1996-07-01), Witzel et al.
Lepor, H. Proc. of Am. Urological A'ssn, vol. 155 May 1996 Supplement p. 587A, abstract 1105.
Sakurai et al., Tetrahedron, vol. 46, No. 3 (1990), pp. 761-774, "Stereocontrolled synthesis of (-)-prezizanol, (-)-prezizaene, their epimers and (-)-allokhusiol".
Templeton et al., J. Chem. Soc. Perk., vol. 1, No. 6 (1987), pp. 1361-1368, "Synthesis of ring-A and -B substituted 17alpha-acetoxypregnan-20-one derivatives . . .".
Larpent et al., Tetra. Letters, vol. 28, No. 22 (1987), pp. 2507-2510, "Catalytic hydrogenation of olefins in biphasic water-liquid system".
Kharchenko et al., Zh. Org. Khim., vol. 23, No. 3 (1987), pp. 576-581, "Stereoselective synthesis of hydroxanthenes".
Abad et al., Tetra. Letters, vol. 27, No. 28 (1986), pp. 3289-3292, "An approach to erythrophleum alkaloids. Synthesis of methyl(-)-4-epi-cassamate".
Stork et al., J. Am. Chem. Soc., vol. 105 (1983), pp. 1072-1073, "Stereocontrol in homogeneous catalytic hydrogenation via hydroxyl group coordination".
Suggs et al., Tetra. Letters, vol. 72 (1981), pp. 303-306, "Facile
Kollar et al., J. Molecular Catalysis, vol. 47, No. 3 (1988), pp. 33-39, "Stereoselective reduction of steroids with in situ prepared phosphine rhodium catalysts".
Harris et al., Proc. Natl. Acad. Sci. USA, vol. 89 (1992), pp. 10787-10791, "Identification and selective inhibition of an isozyme of steroid 5alpha-reductase in human scalp".
Doyle et al., J. Org. Chem., vol. 43, No. 4 (1978), pp. 693-696, "Silane reductions in acidic media, 10. ionic hydrogenation of cycloalkenes, stereoselectivity and mechanism".
Rasmusson et al., J. Med. Chem., vol. 27 (1984), pp. 1690-1701, "Azasteroids as inhibitors of rat prostatic 5alpha-reductase".
Rasmusson et al., J. Med. Chem., vol. 29 (1986), pp. 2298-2315, "Azasteroids: Structure-activity relationships for inhibtion of 5alpha-reductase and of androgen receptor binding".
Jones et al., J. Med. Chem., vol. 36 (1993), pp. 421-423, "Nonsteroidal inhibitors of human type I steroid 5-alpha-reductase".
Cannon et al., Synthesis Commun. (Jun. 1986), pp. 494-496, "Stereospecific
Murahashi et al., J. Org. Chem., vol. 57 (1992), pp. 2521-2523, "Ruthenium-catalyzed hydration of nitriles and transformation of -keto nitriles to ene-lactams".
Boyle et al., Urology, "Prostate Volume Predicts Outcome of Treatment of Benign Prostatic Hyperplasia with Finasteride: Meta-Analysis of Randomized Clinical Trials", vol. 48, No. 3, Sep. 1996, pp. 398-405.

Affiliated with

Also associated with

Rating

Process for the stereoselective reduction of steroid enelactams does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for the stereoselective reduction of steroid enelactams, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for the stereoselective reduction of steroid enelactams will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1609095